ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Brilinta found to reduce bleeding vs dual therapy
April 01, 2020AstraZeneca has announced that the Phase IV independent TWILIGHT trial, Brilinta (ticagrelor) monotherapy reduced bleeding complications with no increased risk of ischaemic events in patients with diabetes undergoing percutaneous coronary intervention. -
Dual Therapy Might Be Advance Against Genital Herpes, Animal Study Suggests
August 02, 2019It's only been tried so far in guinea pigs, but researchers say a combination of a vaccine and a medicated cream could greatly lower recurrence of genital herpes.
Pharma Sources Insight January 2025
